Knockout of DNMT1 using CRISPR gene-editing technology confers resistance to DNMT inhibitors in human breast cancer cells

Laranjeira, AB; Huang, E; Rubinstein, L; Nguyen, D; Yang, SX

CANCER RESEARCH, 2019; 79 (13):